This study showed the efficiency of the liposomal nanocomplex in cancer stem cell targeting and downregulation of MALAT1 by anti-MALAT1-siRNA, leading to decreased growth, stemness, and the migration of glioblastoma cells. The gene discussed is MALAT1; the disease is glioblastoma.